INS and bacterial infectious disease: Herein, insulin was chosen as a model growth factor for delivery from the nanoglue to the in vitro diabetic wound model since reportedly topical application of insulin has been found to accelerate healing.[39, 40] Concurrently, ROS can effectively manage bacterial infections without resistance in the early stage but needs to be removed later for prosperous healing.[41, 42] Understandably, in situ ROS generation and scavenging is an orthogonal aspect seldom taken care of simultaneously by a single agent.